Physician profile
Heng Wang
NPI 1255588406
$10,881.88
in general payments reported to CMS, 2019-2025
14 companies · $261 in 2025
The $261 reported for 2025 was more than what 81% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.55 · 2022: $253 · 2023: $9,987 · 2024: $359 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,370 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,400 · Food and Beverage: $803 · Education: $35.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,370.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,400.00 |
| Food and Beverage | $802.52 |
| Education | $35.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Albireo Pharma, INC. | $8,370.00 | 2023 | Bylvay |
| Ipsen Biopharmaceuticals, INC | $1,463.26 | 2023-2025 | Bylvay |
| Biomarin Pharmaceutical INC. | $552.28 | 2022-2025 | Palynziq, Kuvan |
| Biogen, INC. | $93.17 | 2024-2025 | Skyclarys |
| Sarepta Therapeutics, INC. | $74.62 | 2025 | |
| Alexion Pharmaceuticals, INC. | $72.02 | 2021-2024 | Strensiq |
| Genzyme Corporation | $71.96 | 2023 | |
| Acadia Pharmaceuticals INC | $44.45 | 2024 | Daybue |
| Ptc Therapeutics, INC. | $35.07 | 2025 | Sephience |
| Rhythm Pharmaceuticals, INC. | $32.71 | 2024 | |
| Immedica Pharma US, INC. | $23.00 | 2025 | Ztalmy |
| Pfizer INC. | $20.25 | 2024 | |
| Janssen Pharmaceuticals, INC | $14.71 | 2024 | Xarelto |
| Philips North America LLC | $14.38 | 2024 | (Ck7) Extended Holter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heng Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.